azacitidine has been researched along with Genetic Predisposition in 28 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (25.00) | 29.6817 |
| 2010's | 20 (71.43) | 24.3611 |
| 2020's | 1 (3.57) | 2.80 |
| Authors | Studies |
|---|---|
| Cazzola, M | 1 |
| Albano, F; Anelli, L; Brunetti, C; Carluccio, P; Casieri, P; Coccaro, N; Cumbo, C; Impera, L; Minervini, A; Minervini, CF; Orsini, P; Parciante, E; Ricco, A; Specchia, G; Tota, G; Zagaria, A | 1 |
| Bao, Z; Feng, Y; Guo, T; Jiang, C; Jiang, T; Li, M; Liu, Q; Sun, L; Wang, H; Yan, Z; Yang, X; Zhang, C; Zhang, Q | 1 |
| Bivalacqua, T; Brait, M; Driscoll, T; Hoque, MO; Maldonado, L; Michailidi, C; Munari, E; Netto, GJ; Schoenberg, M; Schultz, L; Sidransky, D | 1 |
| Sakata-Yanagimoto, M | 1 |
| Abdolhosseini, M; Benakanakere, M; Finoti, LS; Hosur, K; Kinane, DF | 1 |
| Dong, Z; Guo, W; Guo, X; Guo, Y; Kuang, G; Shen, S; Wang, C | 1 |
| Chim, CS; Li, ZY; Wang, LQ; Wong, KY; Zhang, Q | 1 |
| Gu, W; Li, H; Li, X; Liu, H; Peng, T; Tang, Y | 1 |
| Chen, X; Gan, W; Han, X; Li, D; Lin, X; Liu, Y; Meng, X; Wang, L; Xiang, Z; Zhang, P | 1 |
| Li, D; Li, T; Liang, L; Liu, J; Nong, L; Qu, L; Zhang, B; Zhang, Z; Zheng, Y | 1 |
| Banelli, B; Barbagallo, C; Barbagallo, D; Di Mauro, S; Di Pietro, C; Magro, G; Maugeri, M; Purrello, F; Purrello, M; Ragusa, M; Romani, M | 1 |
| Li, H; Luan, P; Peng, W; Wang, K; Xu, Y; Zhang, P; Zhuang, J | 1 |
| Du, W; Huang, JA; Lei, Z; Liu, Z; Qian, Q; Qin, H; Shen, D; Zeng, Y; Zhu, J | 1 |
| Al Tuwaijri, A; Bérubé, J; Elzein, S; Farias, R; Goodyer, CG; Ho, B; Kohan-Ghadr, HR; Laprise, C; Moussette, S; Naumova, AK; Rousseau, S | 1 |
| Maekita, T; Nakajima, T; Nakazawa, K; Niwa, T; Ushijima, T; Yamashita, S | 1 |
| De Grazia, G; Loddo, S; Teti, D; Tripodo, B; Venza, I; Venza, M; Visalli, M | 1 |
| Chen, XW; Cheng, HY; Cheng, L; Liu, YD; Lou, G | 1 |
| Altendorf-Hofmann, A; Chen, Y; Hotovy, S; Knösel, T; Petersen, I; Settmacher, U | 1 |
| Chen, J; Gou, Z; Li, P; Liu, R; Wang, H; Wen, J; Zhao, G; Zheng, M; Zhu, Y | 1 |
| Bermejo, JL; Claus, R; Dienemann, H; Gu, L; Jacobsson, H; Meister, M; Muley, T; Peil, B; Plass, C; Risch, A; Sarkisyan, N; Scherf, DB | 1 |
| Eisenhofer, G; Hagelgans, A; Lehnert, R; Menschikowski, M; Platzbecker, U; Schönefeldt, C; Siegert, G; Thiede, C; Vogel, M | 1 |
| Ikeda, Y; Inoue, H; Mimori, K; Mori, M; Murayama, S; Ogawa, K; Okamoto, M; Saku, M; Tanaka, F; Utsunomiya, T; Yamashita, K | 1 |
| Aburatani, H; Hayashi, H; Kaneda, A; Kaneshiro, K; Kozaki, T; Nagae, G; Sugisaki, H; Tsutsumi, S | 1 |
| Bosenberg, M; Bradbury, CM; Curley, DP; Duraisamy, S; Hobbs, C; Muthusamy, V; Nelson, B | 1 |
| Huang, W; Li, B; Tian, XL; Wu, LY; Yu, LF; Zhang, YF; Zhong, J | 1 |
| Cui, X; Liu, T; Meng, WT; Xi, YM; Ye, XS | 1 |
| Noma, H; Shibahara, T; Tanzawa, H; Uzawa, K; Yakushiji, T; Yamamoto, N | 1 |
2 review(s) available for azacitidine and Genetic Predisposition
| Article | Year |
|---|---|
Myelodysplastic Syndromes.
Topics: Azacitidine; Decitabine; Enzyme Inhibitors; Erythrocyte Transfusion; Genetic Predisposition to Disease; Humans; Leukemia, Myeloid, Acute; Mutation; Myelodysplastic Syndromes; Stem Cell Transplantation; Transplantation, Homologous; Watchful Waiting | 2020 |
[TET2 dysregulation in hematologic malignancies].
Topics: Azacitidine; Cytosine; Decitabine; Dioxygenases; DNA-Binding Proteins; Enzyme Inhibitors; Epigenesis, Genetic; Genetic Predisposition to Disease; Hematologic Neoplasms; Humans; Methylation; Molecular Targeted Therapy; Multigene Family; Mutation; Neoplasm Proteins; Proto-Oncogene Proteins | 2014 |
26 other study(ies) available for azacitidine and Genetic Predisposition
| Article | Year |
|---|---|
Droplet digital PCR for the quantification of Alu methylation status in hematological malignancies.
Topics: Adult; Aged; Aged, 80 and over; Alu Elements; Azacitidine; Biomarkers, Tumor; Cell Line, Tumor; Decitabine; DNA Methylation; DNA Modification Methylases; Enzyme Inhibitors; Feasibility Studies; Female; Genetic Predisposition to Disease; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid; Male; Middle Aged; Myelodysplastic Syndromes; Phenotype; Polymerase Chain Reaction; Predictive Value of Tests; Reproducibility of Results; Retrospective Studies | 2018 |
Integrated analysis using methylation and gene expression microarrays reveals PDE4C as a prognostic biomarker in human glioma.
Topics: Adult; Aged; Azacitidine; Biomarkers, Tumor; Cell Line, Tumor; Cell Movement; Cyclic Nucleotide Phosphodiesterases, Type 4; Decitabine; DNA Methylation; Epigenesis, Genetic; Female; Gene Expression Regulation, Neoplastic; Genetic Predisposition to Disease; Glioma; Humans; Male; Middle Aged; Promoter Regions, Genetic; Survival Analysis; Tumor Suppressor Protein p53 | 2014 |
An epigenetic marker panel for recurrence risk prediction of low grade papillary urothelial cell carcinoma (LGPUCC) and its potential use for surveillance after transurethral resection using urine.
Topics: Adult; Aged; Aged, 80 and over; Azacitidine; Biomarkers, Tumor; Case-Control Studies; Cyclin A1; Cyclin D2; Decitabine; DNA Methylation; Epigenesis, Genetic; Female; Genetic Predisposition to Disease; Humans; Hydroxamic Acids; Male; Middle Aged; Neoplasm Grading; Neoplasm Recurrence, Local; Predictive Value of Tests; Promoter Regions, Genetic; Urinary Bladder Neoplasms | 2014 |
TLR2 promoter hypermethylation creates innate immune dysbiosis.
Topics: Animals; Azacitidine; Bacteroidaceae Infections; Cell Culture Techniques; Chronic Periodontitis; CpG Islands; Decitabine; Disease Models, Animal; DNA Methylation; DNA Modification Methylases; Dysbiosis; Epigenesis, Genetic; Epithelial Cells; Genetic Predisposition to Disease; Gingiva; Host-Pathogen Interactions; Humans; Immunity, Innate; Inflammation Mediators; Interleukin-1beta; Mice; Mice, Inbred BALB C; Porphyromonas gingivalis; Toll-Like Receptor 2 | 2015 |
RASSF5A, a candidate tumor suppressor, is epigenetically inactivated in esophageal squamous cell carcinoma.
Topics: Adaptor Proteins, Signal Transducing; Adult; Aged; Alternative Splicing; Apoptosis; Apoptosis Regulatory Proteins; Azacitidine; Biomarkers, Tumor; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Cytidine Triphosphate; DNA Methylation; Esophageal Neoplasms; Esophagus; Female; Genes, Tumor Suppressor; Genetic Predisposition to Disease; Humans; Hydroxamic Acids; Male; Middle Aged; Monomeric GTP-Binding Proteins; Neoplasm Invasiveness; Prognosis; Promoter Regions, Genetic; Protein Isoforms; Protein Synthesis Inhibitors; RNA, Messenger, Stored | 2015 |
Infrequent DNA methylation of miR-9-1 and miR-9-3 in multiple myeloma.
Topics: Azacitidine; Biomarkers, Tumor; Case-Control Studies; Cell Line, Tumor; Decitabine; Disease Progression; DNA Methylation; DNA Modification Methylases; Enzyme Inhibitors; Gene Expression Regulation, Neoplastic; Genetic Predisposition to Disease; Humans; MicroRNAs; Multiple Myeloma; Phenotype; Promoter Regions, Genetic; Recurrence; Treatment Outcome | 2015 |
Hypermethylation of the HLA-G promoter is associated with preeclampsia.
Topics: Adult; Azacitidine; Case-Control Studies; Cell Line; CpG Islands; Decitabine; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Enzyme Inhibitors; Epigenesis, Genetic; Female; Genetic Association Studies; Genetic Predisposition to Disease; HLA-G Antigens; Humans; Phenotype; Placenta; Pre-Eclampsia; Pregnancy; Promoter Regions, Genetic; RNA Interference; Transfection; Trophoblasts | 2015 |
Correlation between the germline methylation status in ERβ promoter and the risk in prostate cancer: a prospective study.
Topics: Aged; Aged, 80 and over; Azacitidine; Case-Control Studies; Cell Line, Tumor; Decitabine; DNA Methylation; Enzyme Inhibitors; Estrogen Receptor beta; Gene Expression Regulation, Neoplastic; Genetic Predisposition to Disease; Humans; Male; Middle Aged; Promoter Regions, Genetic; Prospective Studies; Prostatic Neoplasms | 2016 |
Hypermethylation of PRDM1/Blimp-1 promoter in extranodal NK/T-cell lymphoma, nasal type: an evidence of predominant role in its downregulation.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Azacitidine; Biomarkers; Cell Line, Tumor; Decitabine; DNA Methylation; Epigenesis, Genetic; Female; Gene Expression Regulation, Neoplastic; Gene Silencing; Genetic Predisposition to Disease; Humans; Immunohistochemistry; Lymphoma, Extranodal NK-T-Cell; Male; MicroRNAs; Middle Aged; Positive Regulatory Domain I-Binding Factor 1; Promoter Regions, Genetic; Young Adult | 2017 |
Altered expression of miRNAs and methylation of their promoters are correlated in neuroblastoma.
Topics: Animals; Azacitidine; Cell Line, Tumor; Cell Proliferation; Computational Biology; CpG Islands; Databases, Genetic; Decitabine; DNA Methylation; DNA Modification Methylases; Enzyme Inhibitors; Epigenesis, Genetic; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Regulatory Networks; Genetic Predisposition to Disease; High-Throughput Nucleotide Sequencing; Humans; Kaplan-Meier Estimate; Mice; MicroRNAs; Neuroblastoma; Phenotype; Prognosis; Promoter Regions, Genetic; Protein Interaction Maps; Signal Transduction; Time Factors | 2016 |
The Yin-Yang Dynamics of DNA Methylation Is the Key Regulator for Smooth Muscle Cell Phenotype Switch and Vascular Remodeling.
Topics: 5-Methylcytosine; Animals; Aorta; Aortic Diseases; Apolipoproteins E; Atherosclerosis; Azacitidine; Cell Dedifferentiation; Cell Movement; Cell Proliferation; Cells, Cultured; Decitabine; Diet, High-Fat; Dioxygenases; Disease Models, Animal; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; DNA-Binding Proteins; Enzyme Inhibitors; Epigenesis, Genetic; Genetic Predisposition to Disease; Mice, Knockout; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Nuclear Proteins; Phenotype; Promoter Regions, Genetic; Proto-Oncogene Proteins; Rats; Signal Transduction; Time Factors; Trans-Activators; Vascular Remodeling | 2017 |
Aberrant promoter methylation of hOGG1 may be associated with increased risk of non-small cell lung cancer.
Topics: A549 Cells; Aged; Asian People; Azacitidine; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Case-Control Studies; Chi-Square Distribution; China; Decitabine; DNA Glycosylases; DNA Methylation; DNA Modification Methylases; Enzyme Inhibitors; Female; Gene Frequency; Genetic Association Studies; Genetic Predisposition to Disease; Haplotypes; Humans; Logistic Models; Lung Neoplasms; Male; Middle Aged; Odds Ratio; Phenotype; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Risk Assessment; Risk Factors | 2017 |
Role of DNA methylation in expression control of the IKZF3-GSDMA region in human epithelial cells.
Topics: Alleles; Amino Acid Motifs; Azacitidine; Binding Sites; Cell Line; DNA Methylation; Egg Proteins; Epithelial Cells; Gene Expression Profiling; Gene Expression Regulation; Genetic Predisposition to Disease; Genome-Wide Association Study; Genotype; HEK293 Cells; Humans; Ikaros Transcription Factor; MCF-7 Cells; Membrane Proteins; Neoplasm Proteins; Phenotype; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Up-Regulation | 2017 |
The presence of a methylation fingerprint of Helicobacter pylori infection in human gastric mucosae.
Topics: Azacitidine; Cell Line, Tumor; CpG Islands; Decitabine; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Epigenesis, Genetic; Gastric Mucosa; Genetic Predisposition to Disease; Helicobacter Infections; Helicobacter pylori; Humans; Promoter Regions, Genetic; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sulfites | 2009 |
FOXE1 is a target for aberrant methylation in cutaneous squamous cell carcinoma.
Topics: Aged; Antimetabolites, Antineoplastic; Azacitidine; Carcinoma, Squamous Cell; Decitabine; DNA Methylation; DNA, Neoplasm; Female; Forkhead Transcription Factors; Genetic Predisposition to Disease; Humans; Male; Middle Aged; Neoplasm Proteins; Promoter Regions, Genetic; RNA, Messenger; RNA, Neoplasm; Skin Neoplasms | 2010 |
DNA methylation and carcinogenesis of PRDM5 in cervical cancer.
Topics: Azacitidine; Cell Line, Tumor; CpG Islands; Decitabine; DNA Methylation; DNA Modification Methylases; DNA-Binding Proteins; Female; Gene Expression Regulation, Neoplastic; Genetic Predisposition to Disease; HeLa Cells; Humans; Promoter Regions, Genetic; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transcription Factors; Uterine Cervical Neoplasms | 2010 |
Loss of desmocollin 1-3 and homeobox genes PITX1 and CDX2 are associated with tumor progression and survival in colorectal carcinoma.
Topics: Aged; Aged, 80 and over; Azacitidine; CDX2 Transcription Factor; Cell Line, Tumor; Colorectal Neoplasms; Desmocollins; Disease Progression; Female; Gene Expression Regulation, Neoplastic; Genetic Predisposition to Disease; Homeodomain Proteins; Humans; Immunohistochemistry; Male; Multivariate Analysis; Paired Box Transcription Factors; Prognosis; Reverse Transcriptase Polymerase Chain Reaction; Survival Analysis | 2012 |
Epigenetic modification of TLRs in leukocytes is associated with increased susceptibility to Salmonella enteritidis in chickens.
Topics: Animals; Avian Proteins; Azacitidine; Bacterial Load; Base Sequence; Chickens; Cytokines; Decitabine; DNA Primers; Epigenesis, Genetic; Genetic Predisposition to Disease; Hydroxamic Acids; Leukocytes; Poultry Diseases; Salmonella enteritidis; Salmonella Infections, Animal; Toll-Like Receptors | 2012 |
Epigenetic screen identifies genotype-specific promoter DNA methylation and oncogenic potential of CHRNB4.
Topics: Azacitidine; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Decitabine; DNA Methylation; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Genetic Predisposition to Disease; Genotype; Humans; Lung Neoplasms; Nerve Tissue Proteins; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Receptors, Nicotinic | 2013 |
Aberrant methylation of the M-type phospholipase A(2) receptor gene in leukemic cells.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Azacitidine; Decitabine; DNA Methylation; Female; Genes, Tumor Suppressor; Genetic Predisposition to Disease; Humans; Jurkat Cells; Leukemia; Male; Middle Aged; Myelodysplastic Syndromes; Receptors, Phospholipase A2; U937 Cells; Young Adult | 2012 |
Genomic screens for genes upregulated by demethylation in colorectal cancer: possible usefulness for clinical application.
Topics: Aged; Antimetabolites, Antineoplastic; Apolipoproteins; Apolipoproteins D; Azacitidine; Base Sequence; Cell Line, Tumor; Colorectal Neoplasms; CpG Islands; DNA Methylation; Female; Gene Expression Regulation, Neoplastic; Genetic Predisposition to Disease; Genome, Human; HT29 Cells; Humans; Immunohistochemistry; Male; Middle Aged; Oligonucleotide Array Sequence Analysis; RNA, Messenger; Survival Analysis; Up-Regulation | 2005 |
High-resolution mapping of DNA methylation in human genome using oligonucleotide tiling array.
Topics: Acetylation; Azacitidine; Binding Sites; Cell Line, Tumor; Colorectal Neoplasms; Computational Biology; Decitabine; DNA Methylation; Gene Expression Regulation, Neoplastic; Genetic Predisposition to Disease; Genome, Human; HCT116 Cells; Histones; Homeodomain Proteins; Humans; Microarray Analysis; Oligonucleotide Probes; Sequence Analysis, DNA | 2007 |
Epigenetic silencing of novel tumor suppressors in malignant melanoma.
Topics: Animals; Azacitidine; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Cells, Cultured; CpG Islands; Decitabine; DNA Methylation; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Gene Silencing; Genetic Predisposition to Disease; Homeodomain Proteins; Humans; Intracellular Signaling Peptides and Proteins; Male; Melanoma; Melanoma, Experimental; Mice; Mice, Nude; Protein-Tyrosine Kinases; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Syk Kinase; Transfection; Transplantation, Heterologous; Tumor Suppressor Proteins | 2006 |
Downregulation and CpG island hypermethylation of NES1/hK10 gene in the pathogenesis of human gastric cancer.
Topics: Antimetabolites, Antineoplastic; Azacitidine; Cell Line, Transformed; Cell Line, Tumor; CpG Islands; Decitabine; DNA Methylation; Down-Regulation; Gene Expression Regulation, Neoplastic; Genetic Predisposition to Disease; Humans; In Situ Hybridization; Kallikreins; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Stomach Neoplasms | 2007 |
[Methylation of P15INK4B gene in patients with myelodysplastic syndromes and demethylating effects of drugs].
Topics: Arsenic Trioxide; Arsenicals; Azacitidine; Cyclin-Dependent Kinase Inhibitor p15; Decitabine; Disease Progression; DNA Methylation; Genetic Predisposition to Disease; Humans; Leukemia; Myelodysplastic Syndromes; Oxides | 2007 |
Analysis of the ANA gene as a candidate for the chromosome 21q oral cancer susceptibility locus.
Topics: Azacitidine; Cell Cycle Proteins; Chromosomes, Human, Pair 21; Decitabine; DNA Methylation; Enzyme Inhibitors; Gene Expression Regulation, Neoplastic; Gene Silencing; Genetic Predisposition to Disease; Humans; Loss of Heterozygosity; Mutation; Polymerase Chain Reaction; Polymorphism, Single-Stranded Conformational; Proteins; RNA, Messenger; Tumor Cells, Cultured | 2001 |